About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (BMY) has been publicly traded since 1972, making it a 54-year-old public company. It operates in the Drug Manufacturers - General industry within the Healthcare sector. The company is headquartered in Princeton, United States and employs approximately 32,500 people. With a market capitalization of $120 billion, BMY is a large established company.
Key Statistics
- Current Price
- $59.29
- Market Cap
- $120.73B
- 52-Week High
- $62.89
- 52-Week Low
- $42.52
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +11.21% | $53.31 | $59.28 |
| 2025 | +0.11% | $53.25 | $53.31 |
| 2024 | +15.81% | $45.98 | $53.25 |
| 2023 | -26.14% | $62.26 | $45.98 |
| 2022 | +18.98% | $52.33 | $62.26 |
| 2021 | +2.88% | $50.87 | $52.33 |
| 2020 | +0.41% | $50.66 | $50.87 |
| 2019 | +27.74% | $39.66 | $50.66 |
| 2018 | -12.90% | $45.53 | $39.66 |
| 2017 | +7.71% | $42.27 | $45.53 |
| 2016 | -13.49% | $48.86 | $42.27 |
| 2015 | +19.26% | $40.97 | $48.86 |
| 2014 | +14.18% | $35.88 | $40.97 |
| 2013 | +69.96% | $21.11 | $35.88 |
| 2012 | -3.81% | $21.95 | $21.11 |
| 2011 | +39.44% | $15.74 | $21.95 |
| 2010 | +8.73% | $14.48 | $15.74 |
| 2009 | +14.83% | $12.61 | $14.48 |
| 2008 | -6.03% | $13.42 | $12.61 |
| 2007 | +4.80% | $12.80 | $13.42 |
| 2006 | +19.90% | $10.68 | $12.80 |
| 2005 | -6.14% | $11.38 | $10.68 |
| 2004 | -7.24% | $12.26 | $11.38 |
| 2003 | +29.14% | $9.50 | $12.26 |
| 2002 | -52.40% | $19.95 | $9.50 |
| 2001 | -26.16% | $27.02 | $19.95 |
| 2000 | +17.10% | $23.08 | $27.02 |
| 1999 | -2.80% | $23.74 | $23.08 |
| 1998 | +42.95% | $16.61 | $23.74 |
| 1997 | +77.07% | $9.38 | $16.61 |
| 1996 | +32.16% | $7.10 | $9.38 |
| 1995 | +53.30% | $4.63 | $7.10 |
| 1994 | +6.11% | $4.36 | $4.63 |
| 1993 | -9.46% | $4.82 | $4.36 |
| 1992 | -21.18% | $6.11 | $4.82 |
| 1991 | +35.82% | $4.50 | $6.11 |
| 1990 | +24.08% | $3.63 | $4.50 |
| 1989 | +28.88% | $2.81 | $3.63 |
| 1988 | +14.40% | $2.46 | $2.81 |
| 1987 | +2.84% | $2.39 | $2.46 |
| 1986 | +27.54% | $1.88 | $2.39 |
| 1985 | +30.56% | $1.44 | $1.88 |
| 1984 | +28.17% | $1.12 | $1.44 |
| 1983 | +30.52% | $0.86 | $1.12 |
| 1982 | +31.20% | $0.65 | $0.86 |
| 1981 | +9.13% | $0.60 | $0.65 |
| 1980 | +40.53% | $0.43 | $0.60 |
| 1979 | +7.87% | $0.40 | $0.43 |
| 1978 | +10.25% | $0.36 | $0.40 |
| 1977 | +1.32% | $0.35 | $0.36 |
| 1976 | +2.09% | $0.35 | $0.35 |
| 1975 | +40.95% | $0.25 | $0.35 |
| 1974 | +11.81% | $0.22 | $0.25 |
| 1973 | -30.94% | $0.32 | $0.22 |
Valuation
BMY currently trades at a trailing P/E ratio of 17.1, which is considered moderate relative to the broader market. The forward P/E of 9.6 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 6.5. The price-to-sales ratio is 2.5.
Dividends
Bristol-Myers Squibb Company pays a dividend to shareholders with a current yield of 4.27%. This translates to $2.52 per share annually. The payout ratio of 72% indicates moderate dividend coverage.
Risk & Volatility
BMY has a beta of 0.27, indicating it is less volatile than the overall market. The stock's 52-week range is $42.52 to $62.89, and it currently trades near its 52-week high.
Analyst Ratings
Based on 25 analyst opinions, BMY has a consensus "hold" rating. The average price target of $62.36 suggests 5.6% upside from current levels.
Frequently Asked Questions
What does Bristol-Myers Squibb Company do? ▼
Bristol-Myers Squibb Company is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in Princeton, United States.
What sector is BMY in? ▼
BMY operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
When did BMY go public? ▼
Bristol-Myers Squibb Company went public in 1972, making it a 54-year-old public company as of 2026.
How much would $1,000 invested in BMY 5 years ago be worth today? ▼
A $1,000 investment in BMY five years ago would be worth approximately $1,194 today, representing a 19.4% return.
Does BMY pay dividends? ▼
Yes, Bristol-Myers Squibb Company pays a dividend with a current yield of 4.27%, which is $2.52 per share annually.
What is BMY's market cap? ▼
Bristol-Myers Squibb Company has a market capitalization of $120 billion, classifying it as a large-cap company.
What is BMY's P/E ratio? ▼
BMY has a trailing P/E ratio of 17.1 and a forward P/E of 9.6, which measures how much investors are paying per dollar of earnings.
Is BMY a buy, hold, or sell? ▼
Based on 25 opinions, BMY has a consensus "hold" rating. The average price target is $62.36.
Last updated: 3/14/2026